Ozgur, E. Et Al. 2020. Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer. CANCER BIOMARKERS , vol.27, no.1 , 11-17.

Ozgur, E., Ferhatoglu, F., Sen, F., Saip, P., & Gezer, U., (2020). Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer. CANCER BIOMARKERS , vol.27, no.1, 11-17.

Ozgur, Emre Et Al. "Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer," CANCER BIOMARKERS , vol.27, no.1, 11-17, 2020

Ozgur, Emre Et Al. "Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer." CANCER BIOMARKERS , vol.27, no.1, pp.11-17, 2020

Ozgur, E. Et Al. (2020) . "Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer." CANCER BIOMARKERS , vol.27, no.1, pp.11-17.

@article{article, author={Emre ÖZGÜR Et Al. }, title={Circulating lncRNA H19 may be a useful marker of response to neoadjuvant chemotherapy in breast cancer}, journal={CANCER BIOMARKERS}, year=2020, pages={11-17} }